Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100005782
Hubei Biocause Heilen Pharmaceutical Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 445.86 m CNY | 453.31 m CNY |
| Gross profit | 128.07 m CNY | 100.20 m CNY |
| Operating income | 100.88 m CNY | 7.41 m CNY |
| EBIT | 100.95 m CNY | 41.44 m CNY |
| Net income | 91.55 m CNY | 34.91 m CNY |
| Diluted EPS – continuing operations | 0.22 CNY | 0.08 CNY |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hubei Biocause Heilen Pharmaceutical Co. Ltd.
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. It is involved in the research and development, production, and sales of chemical raw materials and preparations; and provision of contract research and development, and production services. The company also provides raw material products, including non-steroidal anti-inflammatory raw materials ibuprofen and dexibuprofen, cardiovascular raw materials torsemide and milrinone, anti-tumor raw materials abiraterone acetate, fludarabine phosphate, and granisetron hydrochloride; and preparation products, such as cardiovascular preparations torsemide tablets and non-steroidal anti-inflammatory preparations ibuprofen granules, and other preparations. In addition, it offers non-anti-inflammatory APIs, cardiovascular, anti-tumor, and anticholinergic APIs and intermediates; antipyretic and analgesic, cardiovascular and anti-infective preparations; and chemicals and formulations. Hubei Biocause Heilen Pharmaceutical Co., Ltd. was founded in 1995 and is based in Jingmen, China.
More stocks
- PennyMac Mortgage Investment Trust (PMT)
- PennantPark Floating Rate Capital Ltd. (PFLT)
- Yuanli Chemical Group Co Ltd (603217.SS)
- Guangzhou Boji Medical and Biotechnological Co Ltd (300404.SZ)
- Zhejiang Hongchang Electrical Technology Co. Ltd. (301008.SZ)
- Huarui Electrical Appliance Co Ltd (300626.SZ)
- CSBC Corp Taiwan (2208.TW)
- Sabre Corp (SABR)
- Aura Biosciences, Inc. (AURA)
- Hyundai Energy Solutions Co Ltd (322000.KS)
- Suzhou Huazhijie Telecom Co (603400.SS)
- Shenzhen Weiguang Biological Products Co Ltd (002880.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.